In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Excellence in acute cardiac care

A scientific seminar organised in March 2014, by Radiometer Medical Aps, supported by the Acute Cardiovascular Care Association (ACCA).

Acute Cardiac Care
Spring 2014 saw healthcare professionals and key opinion leaders from around the world gather in the South of France for the thought-provoking seminar Excellence in acute cardiac care, supported by the Acute Cardiovascular Care Association of the European Society of Cardiology.

The event provided an opportunity to hear some of the most prominent names in the field of cardiac biomarker testing deliver an insight into the latest advances in this critical sector, and how they have been successful.

Please find Webcasts of all presentations below.


Day 1:

Welcome and Introduction - A. Jaffe - Mayo Clinic, Rochester, MN, USA.

Natriuretic peptides - A cardiologist view - C. de Filippi - University of Maryland Medical Center, Baltimore, MD, USA.

Natriuretic peptides - An ED doctor view - P. Ray - Tenon Hospital, Paris, France.

Natriuretic peptides in renal disease management - B. Frye - Center for Kidney and High Blood Pressure Diseases, Muenster, Germany.(NOT AVAILABLE)

Q&A on Natriuretic peptides

Pre-analytics in blood gas and immunoassays - G. Salvagno - University Hospital, Verona, Italy.

LEAN presentation - A. Wallseth - General Manager, Radiometer UK and Ireland.

LEAN - Real life story - V. Lindenau-Stockfisch - Paul Gerhardt Diakonie Hospital and Care, Lutherstadt Wittenberg, Germany.

Q&A on pre-analytics and LEANImplementation of POCT quality standards to optimize the clinical process reliability - P. Luppa - Institute for Clinical Chemistry and Pathobiochemistry, Munich, Germany.

Implementation of POC cardiac markers (+IT) - P. Wilke - Klinikum Frankfurt, Frankfurt (Oder), Germany

Q&A on POCT

Day 2:

Evolution of the definition of MI - K. Thygesen - Aarhus University Hospital, Denmark.

Troponin – Serial measurements - A. Jaffe - Mayo Clinic, Rochester, MN, USA.

Comparison of troponin assays - F. Apple - Hennepin County Medical Center, Minneapolis, MN, USA.

Impact of hs troponin on the ED - M. Möckel - Charite University Hospital, Berlin, Germany.

Critical review of troponin at POC - P. Venge - University Hospital, Uppsala, Sweden.

Co-existence of POC and central lab troponins - M. Plebani - University Hospital, Padova, Italy.

Q&A on troponin and POC troponin

Radiometer Medical Aps